Novel Technologies

Novel Technologies

When the Pfizer-BioNTech and Moderna COVID-19 vaccines became publicly available in December 2020, healthcare professionals around the country called them...
When you have a bleeding disorder, staying on top of treatment regimens can prevent devastating consequences. Adherence is associated with...
After decades of research, gene therapy for hemophilia is here—but questions remain.
Telemedicine can bridge the distance between doctor and patients.
Last September, scientists, doctors, advocates and people with hemophilia gathered in Washington, DC, for the National Hemophilia Foundation’s (NHF) 15th...
In May 2018, more than 200 people representing scientific researchers, hemophilia patients, advocates, clinicians and the pharmaceutical industry gathered in...
Welcoming a new NHF-Shire clinical fellow.
Advances in bleeding disorders care rely on research, but is taking part in a study right for you?
Assessing the My Life, Our Future Genotyping Project A recent article in the journal Haemophilia analyzed the My Life, Our...
On February 23 and 24, an international group of researchers from universities, industry and government gathered in Washington, DC, for...
All of the funding for the JGP program comes from donations from NHF chapters and individuals.
We strive toward enrolling 2,000 confirmed hemophilia carriers in the MLOF Research Repository.
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.